首页 > 最新文献

Journal of Clinical Oncology最新文献

英文 中文
CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC). CLARITY-Gastric 01:一项针对CLDN18.2 (CLDN18.2)靶向抗体-药物偶联物sonesitatug vedotin (soneve)的随机3期研究,用于二线或二线(2L+)晚期胃癌或胃食管结癌(GC/GEJC)。
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps462
Yelena Y. Janjigian, Elena Elimova, Jun Zhang, Ming-Huang Chen, Elizabeth Catherine Smyth, Jeeyun Lee, Rui Miao, Silver Liu, Marielle Holmblad, Osama E. Rahma, Rui-Hua Xu
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS462-TPS462, January 2026.
临床肿瘤学杂志,第44卷,第2期,TPS462-TPS462页,2026年1月。
{"title":"CLARITY-Gastric 01: A randomized phase 3 study of sonesitatug vedotin (sone ve), a Claudin18.2 (CLDN18.2)-targeted antibody-drug conjugate, in second- or later-line (2L+) advanced gastric or gastroesophageal junction cancer (GC/GEJC).","authors":"Yelena Y. Janjigian, Elena Elimova, Jun Zhang, Ming-Huang Chen, Elizabeth Catherine Smyth, Jeeyun Lee, Rui Miao, Silver Liu, Marielle Holmblad, Osama E. Rahma, Rui-Hua Xu","doi":"10.1200/jco.2026.44.2_suppl.tps462","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps462","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS462-TPS462, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"38 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery NRG BN007的血脑屏障异质性:对免疫治疗递送的影响
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco-25-01988
Xuan Wang, Xudong Li, Xiaobing Jiang
Journal of Clinical Oncology, Ahead of Print.
临床肿瘤学杂志,印刷前。
{"title":"Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery","authors":"Xuan Wang, Xudong Li, Xiaobing Jiang","doi":"10.1200/jco-25-01988","DOIUrl":"https://doi.org/10.1200/jco-25-01988","url":null,"abstract":"Journal of Clinical Oncology, Ahead of Print. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"28 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145993100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are You Bereaved? 你失去亲人了吗?
IF 41.9 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-25 DOI: 10.1200/JCO-25-00991
Trisha K Paul
{"title":"Are You Bereaved?","authors":"Trisha K Paul","doi":"10.1200/JCO-25-00991","DOIUrl":"10.1200/JCO-25-00991","url":null,"abstract":"","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":"66-67"},"PeriodicalIF":41.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145604448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RIVER-mPDAC: A phase 2b/3 study of ponsegromab for the treatment of cachexia in patients with metastatic pancreatic ductal adenocarcinoma receiving first-line chemotherapy. RIVER-mPDAC: ponsegromab治疗接受一线化疗的转移性胰腺导管腺癌患者的恶病质的2b/3期研究。
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps791
Imran Yousuf Ali, Timothy R. Asmis, Jeffrey Crawford, Richard Francis Dunne, Marie T. Fallon, Alexandra Palmer, Glenn Pixton, Jan Kiszko, Keith D. Wilner, Andrew Hendifar
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS791-TPS791, January 2026.
临床肿瘤学杂志,第44卷,第2期,TPS791-TPS791页,2026年1月。
{"title":"RIVER-mPDAC: A phase 2b/3 study of ponsegromab for the treatment of cachexia in patients with metastatic pancreatic ductal adenocarcinoma receiving first-line chemotherapy.","authors":"Imran Yousuf Ali, Timothy R. Asmis, Jeffrey Crawford, Richard Francis Dunne, Marie T. Fallon, Alexandra Palmer, Glenn Pixton, Jan Kiszko, Keith D. Wilner, Andrew Hendifar","doi":"10.1200/jco.2026.44.2_suppl.tps791","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps791","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS791-TPS791, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"40 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase I study of fulvestrant in combination with 177Lu-DOTATATE for advanced pancreatic neuroendocrine tumors. 氟维司汀联合177Lu-DOTATATE治疗晚期胰腺神经内分泌肿瘤的I期研究。
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps649
Aurelie Desgardin, Nicholas Feinberg, Theodore Karrison, Xavier Keutgen, Chih-Yi Liao
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS649-TPS649, January 2026.
临床肿瘤学杂志,第44卷,第2期,第TPS649-TPS649页,2026年1月。
{"title":"Phase I study of fulvestrant in combination with 177Lu-DOTATATE for advanced pancreatic neuroendocrine tumors.","authors":"Aurelie Desgardin, Nicholas Feinberg, Theodore Karrison, Xavier Keutgen, Chih-Yi Liao","doi":"10.1200/jco.2026.44.2_suppl.tps649","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps649","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS649-TPS649, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"8 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors: The phase 2/3, randomized STELLAR-311 trial. 赞扎利替尼与依维莫司在既往治疗过的晚期神经内分泌肿瘤患者中的疗效:2/3期,STELLAR-311随机试验
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps647
Jonathan R. Strosberg, Changhoon Yoo, Simron Singh, Zhong Wang, Laura Sierra, Ellen Bolotin, Jaume Capdevila
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS647-TPS647, January 2026.
临床肿瘤学杂志,第44卷,第2期,第TPS647-TPS647页,2026年1月。
{"title":"Zanzalintinib versus everolimus in patients with previously treated advanced neuroendocrine tumors: The phase 2/3, randomized STELLAR-311 trial.","authors":"Jonathan R. Strosberg, Changhoon Yoo, Simron Singh, Zhong Wang, Laura Sierra, Ellen Bolotin, Jaume Capdevila","doi":"10.1200/jco.2026.44.2_suppl.tps647","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps647","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS647-TPS647, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"56 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase Ib/II study of ASP-1929 photoimmunotherapy (PIT) for esophageal cancer ineligible for curative standard therapies. ASP-1929光免疫疗法(PIT)治疗不符合标准治疗条件的食管癌的Ib/II期研究。
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps474
Mitsuko Suzuki, Masashi Wakabayashi, Nozomu Fuse, Akihiro Sato, Hiroki Yamashita, Keiichiro Nakajo, Tomohiro Kadota, Tomonori Yano
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS474-TPS474, January 2026.
临床肿瘤学杂志,第44卷,第2期,TPS474-TPS474页,2026年1月。
{"title":"Phase Ib/II study of ASP-1929 photoimmunotherapy (PIT) for esophageal cancer ineligible for curative standard therapies.","authors":"Mitsuko Suzuki, Masashi Wakabayashi, Nozomu Fuse, Akihiro Sato, Hiroki Yamashita, Keiichiro Nakajo, Tomohiro Kadota, Tomonori Yano","doi":"10.1200/jco.2026.44.2_suppl.tps474","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps474","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS474-TPS474, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"21 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard? 卡铂治疗绝经前三阴性乳腺癌:是时候重新考虑新辅助标准了?
IF 41.9 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-21 DOI: 10.1200/JCO-25-02336
Rina K Yadav, Kathy D Miller
{"title":"Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?","authors":"Rina K Yadav, Kathy D Miller","doi":"10.1200/JCO-25-02336","DOIUrl":"10.1200/JCO-25-02336","url":null,"abstract":"","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":"1-4"},"PeriodicalIF":41.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma. 勘误:POLARIX研究比较弥漫性大b细胞淋巴瘤患者Pola-R-CHP和R-CHOP的5年结果。
IF 41.9 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-20 DOI: 10.1200/JCO-25-02667
Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg, Marek Trněný, Georg Lenz, Jeff P Sharman, Charles Herbaux, John M Burke, Matthew Matasar, Graham P Collins, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Antonio Pinto, Shinya Rai, Koji Izutsu, Richard Greil, Larysa Mykhalska, Juan M Bergua-Burgués, Matthew C Cheung, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Yanwen Jiang, Bruce McCall, Saibah Chohan, Matthew Sugidono, Mark Yan, Connie Lee Batlevi, Hervé Tilly, Christopher R Flowers
{"title":"Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.","authors":"Franck Morschhauser, Gilles Salles, Laurie H Sehn, Alex F Herrera, Jonathan W Friedberg, Marek Trněný, Georg Lenz, Jeff P Sharman, Charles Herbaux, John M Burke, Matthew Matasar, Graham P Collins, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Antonio Pinto, Shinya Rai, Koji Izutsu, Richard Greil, Larysa Mykhalska, Juan M Bergua-Burgués, Matthew C Cheung, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Yanwen Jiang, Bruce McCall, Saibah Chohan, Matthew Sugidono, Mark Yan, Connie Lee Batlevi, Hervé Tilly, Christopher R Flowers","doi":"10.1200/JCO-25-02667","DOIUrl":"10.1200/JCO-25-02667","url":null,"abstract":"","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":" ","pages":"71"},"PeriodicalIF":41.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monthly alternating NALIRIFOX and GnP for metastatic pancreatic ductal adenocarcinoma (AltCAP). 转移性胰腺导管腺癌(AltCAP)每月交替使用NALIRIFOX和GnP。
IF 45.3 1区 医学 Q1 ONCOLOGY Pub Date : 2026-01-01 DOI: 10.1200/jco.2026.44.2_suppl.tps798
Siva Poojitha Madala, Vincent Vinciguerra, Marisa Siebel, Tony Philip, Jocelyn Lee Wozney, Riya Patel, Anna Taran Levy, Deeksha Kaura, Bernadette Bingham, Codruta Chiuzan, Elizabeth Cohn, Nicholas James Hornstein, Craig E. Devoe
Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS798-TPS798, January 2026.
临床肿瘤学杂志,第44卷,第2期,TPS798-TPS798页,2026年1月。
{"title":"Monthly alternating NALIRIFOX and GnP for metastatic pancreatic ductal adenocarcinoma (AltCAP).","authors":"Siva Poojitha Madala, Vincent Vinciguerra, Marisa Siebel, Tony Philip, Jocelyn Lee Wozney, Riya Patel, Anna Taran Levy, Deeksha Kaura, Bernadette Bingham, Codruta Chiuzan, Elizabeth Cohn, Nicholas James Hornstein, Craig E. Devoe","doi":"10.1200/jco.2026.44.2_suppl.tps798","DOIUrl":"https://doi.org/10.1200/jco.2026.44.2_suppl.tps798","url":null,"abstract":"Journal of Clinical Oncology, Volume 44, Issue 2_suppl, Page TPS798-TPS798, January 2026. <br/>","PeriodicalId":15384,"journal":{"name":"Journal of Clinical Oncology","volume":"8 1","pages":""},"PeriodicalIF":45.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1